Therapy Areas: Infectious Diseases
Seegene finalises Werfen partnership agreement
9 October 2024 - Seegene Inc, a South Korean provider of solutions for PCR molecular diagnostics, announced on Tuesday that it has finalised a technology-sharing partnership agreement with Spanish dia...
hVIVO reports positive results from RSV antiviral human challenge trial
7 October 2024 - hVIVO plc (AIM: HVO), a specialist contract research organisation (CRO) in infectious disease testing, has announced positive topline results from a Phase 2a Respiratory Syncytial Vir...
Gilead expands global access to lenacapavir for HIV prevention
2 October 2024 - HIV medication company Gilead Sciences Inc (Nasdaq: GILD) announced on Wednesday that it has signed royalty-free voluntary licensing agreements with six generic manufacturers to incre...
Lunaphore partners with Discovery Life Sciences
27 September 2024 - US life sciences company Bio-Techne Corporation (NASDAQ: TECH) announced on Thursday that its spatial biology brand, Lunaphore, is partnering with Discovery Life Sciences (Discover...
Priovant Therapeutics enrols first patients in brepocitinib CLARITY study
24 September 2024 - US biotechnology company Priovant Therapeutics announced on Monday that the first patients have been enrolled in CLARITY, a Phase 3 study assessing brepocitinib in non-anterior non...
TC BioPharm plans Proof of Concept preclinical studies of TCB 008 for treatment of monkey pox
9 September 2024 - Clinical stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications TC BioPharm (Holdings) PLC (TC BioPharm or the comp...